Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.
Fatigue, Leukemia, Lymphoma

About this trial
This is an interventional treatment trial for Fatigue focused on measuring Fatigue, Physical Therapy, Hematological Malignancy
Eligibility Criteria
Inclusion Criteria:
- Patients clinically diagnosed with Leukemia or Lymphoma, in the first or second line of treatment, undergoing high-dose chemotherapy, with or without hematopoietic stem cell transplantation;
- Neurological and cognitive functions preserved;
- Physical conditions that enable participation in physical rehabilitation.
Exclusion Criteria:
- Clinical Complications that contraindicate physical therapy exercises, including the practice of cycle ergometer and resistance exercises;
- Previous musculoskeletal alteration that interferes in physical performance evaluation tests;
- Recent cardiovascular or pulmonary disease;
- Psychiatric or neurological disorder;
- Inability to walk on its own or presence of bone metastasis;
- Adherence on less than 50% of the total sessions of the study.
Sites / Locations
- Fabrício Edler Macagnan
- Universidade Federal de Ciências da Saúde de Porto Alegre
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Active Comparator
Experimental
Leukemia Control Group
Leukemia Experimental Group
Lymphoma Control Group
Lymphoma Experimental Group
In this group the exercise program will be based on the standard protocol of physical therapy.
In this group the exercise program will be based on a periodic resistance training program, with an autoregulated approach within a non-linear model, based on the individual's patient daily response.
In this group the exercise program will be based on the standard protocol of physical therapy.
In this group the exercise program will be based on a periodic resistance training program, with an autoregulated approach within a non-linear model, based on the individual's patient daily response.